Effects of acne management therapies on the levels of microRNAs and acne severity index- A randomized clinical trial

Acne Management therapies on levels of microRNAs

Authors

  • Uzma Rajar Department of Dermatology, Isra University, Hyderabad.
  • Amin Fahim Department of Pathology, People's University of Medical and Health Sciences for Women (PUMHSw) Shaheed Benazirabad.
  • Navaid Kazi Department of Physiology, Isra University, Hyderabad.

Abstract

Introduction The study was aimed to identify the effects of acne treatment protocols to determine their impact on levels of miRNA and acne severity index of acne vulgaris patients after three months of treatment protocol. Methodology The outcome measures were analyzed on two parameters; levels of miRNA and acne severity index. The outcome parameters were recorded twice at baseline; before the start of the treatment session and after completion of 3 months of treatment session.  Extraction of miRNA was performed from serum samples of patients using a TRIzol LS method. Results It was estimated that isotretinoin was turned out to be effective in lowering the value of hsa-mir-223, hsa-mir-21, has-mir-155 and hsa-mir-4273 in comparison to topical clindamycin and IPL therapy whereas IPL treatment was turned out to be significantly better than clindamycin in lowering the value of hsa-mir-21. Conclusion The study had concluded that levels of microRNAs rises among acne vulagris patients and that administration of isotretinoin significantly reduces the levels of miRNA. Key words: Acne Vulgaris, MicroRNAs, isotretinoin, clindamycin & Polymerase Chain Reaction

References

Heng AH, Chew FT. Systematic review of

the epidemiology of acne vulgaris. Sci Rep. 2020;10(1):1-29.

Mohsin N, Hernandez LE, Martin MR, Does AV, Nouri K. Acne treatment review and future perspectives. Dermatol Ther. 2022;35(9):e15719.

Khan AS, Almulhim AF, Alqattan MH, Almakhaitah NF, Alomair FI, Alkhateeb AA. psychological impact of acne vulgaris among young females in the eastern province, Saudi Arabia. Cureus. 2022;14(9): e29378.

Hussain A, Khanum A. Self medication among university students of Islamabad, Pakistan-a preliminary study. Southern Med Rev. 2008;1(1):14-6.

Elawady MS, Mohamed HA, El-Dahshan RM, Mahmmoud AA. Prevalence of Acne among Preadolescent School Students in Damietta Governorate. Int J Med Art. 2020;2(4):779-85.

Bukhari N, Cheema IU, Ahmad Z, Abid MA. Exploring Psychosocial And Mental Health Issues Of Female With Acne Vulgaris: A Phenomenological Study. Harf-o-Sukhan. 2021;5(3):397-407.

Dacy N, Preston A, Nguyen P. 32748 A case series of pediatric cellular neurothekeomas and a review of the histologic spectrum. J Am Acad Dermatol. 2022;87(3):AB8.

Ogé LK, Broussard A, Marshall MD. Acne vulgaris: diagnosis and treatment. Am Fam Phys. 2019;100(8):475-84.

Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Dermatology: how to manage acne vulgaris. Drugs Context. 2021;10:2021-8-6.

Aslan Kayiran M, Karadag AS, Al-Khuzaei S, Chen W, Parish LC. Antibiotic resistance in acne: mechanisms, complications and management. Am J Clin Dermatol. 2020;21(6):813-9.

Anwar R, Tabri F, Anwar AI, Adriani A, Bahar B, Massi MN. The Relationship between Propionibacterium Acnes and Free Fatty Acid Levels of the Skin Surface in Acne Vulgaris Patients. Int J Sci Basic Appl Res (IJSBAR). 2018;37(1):66–73.

Borgia F, Peterle L, Custurone P, Vaccaro M, Pioggia G, Gangemi S. MicroRNA Cross-Involvement in Acne Vulgaris and Hidradenitis Suppurativa: A Literature Review. Int J Mol Sci. 2022;23(6):3241.

Plewig G, Melnik B, Chen W. Acne pathogenesis. InPlewig and Kligmans Acne and Rosacea 2019 (pp. 45-61). Springer, Cham.

Ghumra W, Lee N, Whitehouse H, Bhutani R, Lagos D, Layton AM. MicroRNAs as biomarkers of atrophic scarring in acne: a crossâ€sectional analysis of 41 patients. Clin Exp Dermatol. 2021;46(8):1495-503.

Trakunram K, Champoochana N, Chaniad P, Thongsuksai P, Raungrut P. MicroRNA isolation by trizol-based method and its stability in stored serum and cDNA derivatives. Asian Pac J Cancer Prevent: APJCP. 2019;20(6):1641.

Xu X, Ran X, Tang J, Pradhan S, Dai Y, Zhuang K, Ran Y. Skin Microbiota in Non-inflammatory and Inflammatory Lesions of Acne Vulgaris: The Underlying Changes within the Pilosebaceous Unit. Mycopathologia. 2021;186(6):863-9.

Kutlu Ö. Effect of isotretinoin treatment on the inflammatory markers in patients with acne vulgaris: can monocyte/HDL be a new indicator for inflammatory activity of isotretinoin treatment?. Cut Ocular Toxicol. 2020;39(1):67-70.

Cosansu NC, Yuksekal G, Turan U, Umitfer F, Yaldiz M, Sevimli Dikicier B. Investigation of systemic immune-inflammation index and systemic inflammation response index as an indicator of the anti-inflammatuary effect of isotretinoin in patients with acne vulgaris. Cut Ocular Toxicol. 2022:1-5.

Iraji F, Aghaei A, Motamedi R, Siahpoosh A, Karami MA. Comparison of Topical Herbal Cream and 1% Clindamycin Gel for Treatment of Mild-to-moderate Acne: A Randomized Clinical Trial. Jundishapur J Nat Pharm Prod. 2022;17(3):e114810. https://doi.org/10.5812/jjnpp.114810.

Mokhtari F, Shajari A, Iraji F, Faghihi G, Siadat AH, Sadeghian G, Adibi N. The effectiveness of adapalene 0.1% with intense pulsed light versus benzoyl peroxide 5% with intense pulsed light in the treatment of acne vulgaris: A comparative study. J Res Med Sci. 2019;24(1):101.

Li Y, Xia J, Zhu Y, He S, Liu J, Zeng W, Wang Z. Efficacy and safety of low-level light therapy by delicate pulsed light combined with low-dose oral isotretinoin for the treatment of acne vulgaris: a randomized split-face study. Lasers Med Sci. 2022;37(8):3221-9.

Downloads

Published

2023-07-02

How to Cite

1.
Rajar U, Fahim A, Kazi N. Effects of acne management therapies on the levels of microRNAs and acne severity index- A randomized clinical trial: Acne Management therapies on levels of microRNAs. J Pak Assoc Dermatol [Internet]. 2023Jul.2 [cited 2026Feb.26];33(2):459-65. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2145

Issue

Section

Original Articles